GOCO Form 4: COO Mike Hargis withholds 5,545 shares from RSU vesting

Rhea-AI Filing Summary

GoHealth insider tax-withholding sale tied to RSU vesting. Mike Hargis, the company's Chief Operating Officer, reported a sale of 5,545 shares of Class A common stock on 09/12/2025 at a price of $4.98 per share. The filing states these shares were withheld by the company to satisfy tax withholding obligations related to the vesting of 22,222 restricted stock units granted on 09/12/2022. After the withholding, Hargis beneficially owns 324,993 shares directly. The form indicates the transaction was reported by a single reporting person and executed through an attorney-in-fact.

Positive

• Continued ownership: Reporting person retains 324,993 direct shares after withholding, indicating ongoing insider alignment with shareholder interests
• Clear disclosure: Transaction is documented as a tax-withholding from the vesting of 22,222 RSUs, showing compliance with reporting requirements

Negative

• None.

Insights

Financial Analyst

TL;DR: Routine insider withholding, not an active market sale; minimal informational impact on GoHealth's outlook.

The reported 5,545-share disposition is identified as a tax-withholding event tied to RSU vesting rather than a discretionary open-market sale. The per-share price of $4.98 reflects the withholding calculation, and the reporting person continues to hold a material equity position of 324,993 shares. For investors, this transaction is procedural and does not provide new operational or financial signal about GoHealth's performance.

Corporate Governance Expert

TL;DR: Standard compliance disclosure; demonstrates adherence to Section 16 reporting and tax withholding processes.

The filing documents proper disclosure of a withholding event following RSU vesting, showing governance processes functioning as expected. The reporting person is identified as the Chief Operating Officer, and the transaction is categorized under Code F, consistent with company-forced share transfers for tax obligations. This is a routine governance matter with no indication of unusual insider trading behavior.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Hargis Mike

(Last) (First) (Middle)

222 W MERCHANDISE MART PLAZA SUITE 1750

(Street)

CHICAGO IL 60654

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
GoHealth, Inc. [ GOCO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Operating Officer

3. Date of Earliest Transaction (Month/Day/Year)
09/12/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	09/12/2025		F		5,545(1)	D	$4.98	324,993	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of 22,222 restricted stock units granted to the reporting person on September 12, 2022.

Remarks:

	/s/ Bradley Burd, Attorney-in-fact	09/16/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did GOCO insider Mike Hargis report?

The report documents a withholding of 5,545 Class A shares to satisfy tax obligations tied to RSU vesting.

Why were 5,545 shares disposed of according to the Form 4?

The shares were withheld by the company to satisfy tax withholding for the vesting of 22,222 restricted stock units granted on 09/12/2022.

How many GOCO shares does Mike Hargis beneficially own after the transaction?

He beneficially owns 324,993 shares of Class A common stock following the withholding.

At what price were the withheld shares recorded?

The withheld shares are listed at a price of $4.98 per share in the filing.

What is Mike Hargis's role at GoHealth as stated in the filing?

He is identified as the company's Chief Operating Officer and the form was filed by one reporting person.